These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 24492586

  • 1. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine.
    Szymańska E, Winnicka K, Amelian A, Cwalina U.
    Chem Pharm Bull (Tokyo); 2014; 62(2):160-7. PubMed ID: 24492586
    [Abstract] [Full Text] [Related]

  • 2. Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect.
    Jøraholmen MW, Vanić Z, Tho I, Skalko-Basnet N.
    Int J Pharm; 2014 Sep 10; 472(1-2):94-101. PubMed ID: 24928137
    [Abstract] [Full Text] [Related]

  • 3. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
    Rençber S, Karavana SY, Şenyiğit ZA, Eraç B, Limoncu MH, Baloğlu E.
    Pharm Dev Technol; 2017 Jun 10; 22(4):551-561. PubMed ID: 27055376
    [Abstract] [Full Text] [Related]

  • 4. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration.
    Perioli L, Ambrogi V, Pagano C, Scuota S, Rossi C.
    Int J Pharm; 2009 Jul 30; 377(1-2):120-7. PubMed ID: 19454304
    [Abstract] [Full Text] [Related]

  • 5. Development of a mucoadhesive dosage form for vaginal administration.
    Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C, Rossi S.
    Drug Dev Ind Pharm; 2001 Jul 30; 27(6):541-7. PubMed ID: 11548861
    [Abstract] [Full Text] [Related]

  • 6. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:beta-cyclodextrin complex.
    Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA.
    AAPS PharmSciTech; 2006 Apr 14; 7(2):E38. PubMed ID: 16796356
    [Abstract] [Full Text] [Related]

  • 7. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M, Gu Z, Pan H, Yu H, Xiao K.
    Indian J Exp Biol; 2005 Feb 14; 43(2):150-7. PubMed ID: 15782815
    [Abstract] [Full Text] [Related]

  • 8. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole.
    Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A.
    J Control Release; 2002 Jun 17; 81(3):347-54. PubMed ID: 12044573
    [Abstract] [Full Text] [Related]

  • 9. Controlled-release biodegradable nanoparticles: From preparation to vaginal applications.
    Martínez-Pérez B, Quintanar-Guerrero D, Tapia-Tapia M, Cisneros-Tamayo R, Zambrano-Zaragoza ML, Alcalá-Alcalá S, Mendoza-Muñoz N, Piñón-Segundo E.
    Eur J Pharm Sci; 2018 Mar 30; 115():185-195. PubMed ID: 29208486
    [Abstract] [Full Text] [Related]

  • 10. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
    Karimunnisa S, Atmaram P.
    Drug Dev Ind Pharm; 2013 Sep 30; 39(9):1328-37. PubMed ID: 22866766
    [Abstract] [Full Text] [Related]

  • 11. Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation.
    Sharma G, Jain S, Tiwary AK, Kaur G.
    Acta Pharm; 2006 Sep 30; 56(3):337-45. PubMed ID: 19831282
    [Abstract] [Full Text] [Related]

  • 12. Retention and distribution of two 99mTc-DTPA labelled vaginal dosage forms.
    Chatterton BE, Penglis S, Kovacs JC, Presnell B, Hunt B.
    Int J Pharm; 2004 Mar 01; 271(1-2):137-43. PubMed ID: 15129980
    [Abstract] [Full Text] [Related]

  • 13. Preparation and in vitro evaluation of chitosan microgranules with clotrimazole.
    Szymańska E, Winnicka K.
    Acta Pol Pharm; 2012 Mar 01; 69(3):509-13. PubMed ID: 22594265
    [Abstract] [Full Text] [Related]

  • 14. Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations.
    Tuğcu-Demiröz F, Acartürk F, Erdoğan D.
    Int J Pharm; 2013 Nov 30; 457(1):25-39. PubMed ID: 24036011
    [Abstract] [Full Text] [Related]

  • 15. Entirely S-protected chitosan: A promising mucoadhesive excipient for metronidazole vaginal tablets.
    Lupo N, Fodor B, Muhammad I, Yaqoob M, Matuszczak B, Bernkop-Schnürch A.
    Acta Biomater; 2017 Dec 30; 64():106-115. PubMed ID: 29030305
    [Abstract] [Full Text] [Related]

  • 16. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
    Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C.
    Drug Dev Ind Pharm; 2009 Jul 30; 35(7):769-79. PubMed ID: 19337872
    [Abstract] [Full Text] [Related]

  • 17. Chitosan gels for the vaginal delivery of lactic acid: relevance of formulation parameters to mucoadhesion and release mechanisms.
    Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C.
    AAPS PharmSciTech; 2006 Jul 30; 7(4):104. PubMed ID: 17285750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E, Sanna V, Juliano C, Bonferoni MC, Giunchedi P.
    AAPS PharmSciTech; 2002 Jul 30; 3(3):E20. PubMed ID: 12916935
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.